The global market for Endoscope Sterilization was estimated at US$2.3 Billion in 2024 and is projected to reach US$3.8 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Endoscope Sterilization market.
The rising incidence of endoscope-related infections, regulatory scrutiny on medical device reprocessing, and increasing adoption of single-use endoscopic devices have intensified the demand for advanced sterilization techniques. Traditional cleaning and disinfection methods, such as manual reprocessing and high-level disinfection (HLD), are being supplemented or replaced by more reliable low-temperature sterilization technologies. The shift toward automated endoscope reprocessing (AER) systems, vaporized hydrogen peroxide (VHP) sterilization, and peracetic acid-based sterilization techniques is improving efficiency and reducing risks associated with human error in manual sterilization.
The integration of AI-powered monitoring systems and RFID-based tracking solutions in automated reprocessing units has enhanced compliance with sterilization protocols and documentation accuracy. These smart systems help hospitals track sterilization cycles, prevent recontamination, and ensure compliance with FDA, CDC, and Joint Commission standards. Additionally, the growing emphasis on single-use endoscopes, particularly in bronchoscopy, urology, and ENT procedures, is reshaping the market, reducing dependence on traditional sterilization workflows while improving patient safety.
As healthcare facilities prioritize patient safety and compliance, the adoption of next-generation sterilization technologies, AI-powered tracking, and eco-friendly disinfection solutions is expected to drive sustained growth. With continued innovation in endoscopic reprocessing and single-use device development, the endoscope sterilization market is set for significant advancements in the coming years.
Segments: Product (Sterilizers, Liquid Chemical Sterilization Systems, Automated Endoscope Reprocessors (AERs); Type (Flexible Endoscopes, Rigid Endoscopes); Device Type (Colonoscopes, Bronchoscopes, Duodenoscopes, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Endoscope Sterilization Market - Key Trends & Drivers Summarized
Why Is Endoscope Sterilization Essential for Patient Safety?
Endoscope sterilization is a critical process in infection control, ensuring that flexible and rigid endoscopes used in medical procedures remain free from harmful microorganisms. Endoscopes are widely utilized in gastroenterology, pulmonology, urology, gynecology, and minimally invasive surgeries, making sterilization a high-priority area in hospital hygiene and patient safety protocols. Given the complexity of endoscopic instruments, which have long, narrow lumens and delicate optical components, effective sterilization is essential to prevent cross-contamination and hospital-acquired infections (HAIs).The rising incidence of endoscope-related infections, regulatory scrutiny on medical device reprocessing, and increasing adoption of single-use endoscopic devices have intensified the demand for advanced sterilization techniques. Traditional cleaning and disinfection methods, such as manual reprocessing and high-level disinfection (HLD), are being supplemented or replaced by more reliable low-temperature sterilization technologies. The shift toward automated endoscope reprocessing (AER) systems, vaporized hydrogen peroxide (VHP) sterilization, and peracetic acid-based sterilization techniques is improving efficiency and reducing risks associated with human error in manual sterilization.
What Are the Key Innovations in Endoscope Sterilization?
Technological advancements in endoscope sterilization have focused on enhancing sterility assurance, reducing cycle time, and improving material compatibility. The development of low-temperature hydrogen peroxide plasma sterilization systems has enabled effective reprocessing of heat-sensitive endoscopes without damaging optical or electronic components. Additionally, UV-C light sterilization, ozone sterilization, and electrochemical oxidation-based sterilization are emerging as promising alternatives to traditional chemical disinfectants.The integration of AI-powered monitoring systems and RFID-based tracking solutions in automated reprocessing units has enhanced compliance with sterilization protocols and documentation accuracy. These smart systems help hospitals track sterilization cycles, prevent recontamination, and ensure compliance with FDA, CDC, and Joint Commission standards. Additionally, the growing emphasis on single-use endoscopes, particularly in bronchoscopy, urology, and ENT procedures, is reshaping the market, reducing dependence on traditional sterilization workflows while improving patient safety.
What Is Driving the Growth of the Endoscope Sterilization Market?
The growth in the endoscope sterilization market is driven by increasing endoscopic procedures, rising concerns over HAIs, and stricter regulatory requirements for medical device reprocessing. The growing demand for automated and standardized sterilization solutions, advancements in low-temperature sterilization technologies, and the shift toward disposable endoscopes have contributed to market expansion. Additionally, rising healthcare investments in infection prevention and the expansion of endoscopy centers globally are fueling demand for high-efficiency sterilization systems.As healthcare facilities prioritize patient safety and compliance, the adoption of next-generation sterilization technologies, AI-powered tracking, and eco-friendly disinfection solutions is expected to drive sustained growth. With continued innovation in endoscopic reprocessing and single-use device development, the endoscope sterilization market is set for significant advancements in the coming years.
Report Scope
The report analyzes the Endoscope Sterilization market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Product (Sterilizers, Liquid Chemical Sterilization Systems, Automated Endoscope Reprocessors (AERs); Type (Flexible Endoscopes, Rigid Endoscopes); Device Type (Colonoscopes, Bronchoscopes, Duodenoscopes, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Sterilizers segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 8.4%. The Liquid Chemical Sterilization Systems segment is also set to grow at 9.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $634.4 Million in 2024, and China, forecasted to grow at an impressive 13.2% CAGR to reach $823.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Endoscope Sterilization Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Endoscope Sterilization Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Endoscope Sterilization Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as 3M Company, Advanced Sterilization Products (ASP), ARC Group of Companies Inc., Belimed AG, Cantel Medical (a STERIS company) and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 36 Featured):
- 3M Company
- Advanced Sterilization Products (ASP)
- ARC Group of Companies Inc.
- Belimed AG
- Cantel Medical (a STERIS company)
- Custom Ultrasonics, Inc.
- Ecolab Inc.
- Endo-Technik W. Griesat
- Fortive Corporation
- Getinge AB
- H.W. Andersen Products Ltd.
- Matachana Group
- Nanosonics Limited
- Olympus Corporation
- Shinva Medical Instrument Co., Ltd.
- Steelco S.p.A.
- STERIS plc
- Stryker Corporation
- Tuttnauer
- Wassenburg Medical B.V.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Company
- Advanced Sterilization Products (ASP)
- ARC Group of Companies Inc.
- Belimed AG
- Cantel Medical (a STERIS company)
- Custom Ultrasonics, Inc.
- Ecolab Inc.
- Endo-Technik W. Griesat
- Fortive Corporation
- Getinge AB
- H.W. Andersen Products Ltd.
- Matachana Group
- Nanosonics Limited
- Olympus Corporation
- Shinva Medical Instrument Co., Ltd.
- Steelco S.p.A.
- STERIS plc
- Stryker Corporation
- Tuttnauer
- Wassenburg Medical B.V.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 369 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 2.3 Billion |
Forecasted Market Value ( USD | $ 3.8 Billion |
Compound Annual Growth Rate | 8.5% |
Regions Covered | Global |